{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:48:29Z","timestamp":1789174109396,"version":"build-2803163510"},"reference-count":42,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University, Riyadh, Saudi Arabia","doi-asserted-by":"publisher","award":["RSP2024R357"],"award-info":[{"award-number":["RSP2024R357"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>SARS-CoV, an RNA virus, is contagious and displays a remarkable degree of adaptability, resulting in intricate disease presentations marked by frequent genetic mutations that can ultimately give rise to drug resistance. Targeting its viral replication cycle could be a potential therapeutic option to counter its viral growth in the human body leading to the severe infectious stage. The Mpro of SARS-CoV-2 is a promising target for therapeutic development as it is crucial for viral transcription and replication. The derivatives of \u03b2-diketone and coumarin have already been reported for their antiviral potential and, thus, are considered as a potential scaffold in the current study for the computational design of potential analogs for targeting the viral replication of SARS-CoV-2. In our study, we used novel diketone-hinged coumarin derivatives against the SARS-CoV-2 MPro to develop a broad-spectrum antiviral agent targeting SARS-CoV-2. Through an analysis of pharmacokinetics and docking studies, we identified a list of the top 10 compounds that demonstrated effectiveness in inhibiting the SARS-CoV-2 MPro virus. On the basis of the pharmacokinetics and docking analyses, the top 5 novel coumarin analogs were synthesized and characterized. The thermodynamic stability of compounds KS82 and KS94 was confirmed by their molecular dynamics, and the stability of the simulated system indicated their inhibitory nature. Molecules KS82 and KS94 were further evaluated for their anti-viral potential using Vero E6 cells followed by RT-PCR assay against SARS-CoV-2. The test compound KS82 was the most active with the potential to inhibit SARS-CoV-2 replication in Vero E6 cells. These data indicate that KS82 prevents the attack of the virus and emerges as the primary candidate with promising antiviral properties.<\/jats:p>","DOI":"10.3390\/molecules29061406","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:13:08Z","timestamp":1711012388000},"page":"1406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Design, Synthesis, and Biological Evaluation of Novel Coumarin Analogs Targeted against SARS-CoV-2"],"prefix":"10.3390","volume":"29","author":[{"given":"Kirti","family":"Sharma","sequence":"first","affiliation":[{"name":"Chitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5477-9222","authenticated-orcid":false,"given":"Manjinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumesh C.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Chitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-5475","authenticated-orcid":false,"given":"Somdutt","family":"Mujwar","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4138-3733","authenticated-orcid":false,"given":"Mohit","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Chitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kumar","family":"Mishra","sequence":"additional","affiliation":[{"name":"Chitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3498-4112","authenticated-orcid":false,"given":"Tanveer A.","family":"Wani","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Li, Q., and Kang, C. (2020). Progress in developing inhibitors of SARS-CoV-2 3C-like protease. Microorganisms, 8.","DOI":"10.3390\/microorganisms8081250"},{"key":"ref_3","first-page":"30","article-title":"An Introduction to SARS Coronavirus 2; Comparative Analysis with MERS and SARS Coronaviruses: A Brief Review","volume":"49","author":"Taherizadeh","year":"2020","journal-title":"Iran. J. Public Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1080\/21645515.2020.1807802","article-title":"Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: Advances and prospects in the development of animal models for vaccine and therapeutic research","volume":"16","author":"Sharun","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ye, Z.W., Yuan, S., Yuen, K.S., Fung, S.Y., Chan, C.P., and Jin, D.Y. (2020). Zoonotic origins of human coronaviruses. Int. J. Biol. Sci., 16.","DOI":"10.7150\/ijbs.45472"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wang, Y., Grunewald, M., and Perlman, S. (2020). Coronaviruses. Methods in Molecular Biology, Humana.","DOI":"10.1007\/978-1-0716-0900-2_1"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Abu-Hashem, A.A., and Al-Hussain, S.A. (2022). The Synthesis, Antimicrobial Activity, and Molecular Docking of New 1, 2, 4-Triazole, 1, 2, 4-Triazepine, Quinoline, and Pyrimidine Scaffolds Condensed to Naturally Occurring Furochromones. Pharmaceuticals, 15.","DOI":"10.3390\/ph15101232"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ullrich, S., and Nitsche, C. (2020). The SARS-CoV-2 main protease as drug target. Bioorganic Med. Chem. Lett., 30.","DOI":"10.1016\/j.bmcl.2020.127377"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1002\/mco2.151","article-title":"The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Abu-Hashem, A.A., A Al-Hussain, S., and Zaki, M.E.A. (2020). Synthesis of novel benzodifuranyl; 1,3,5-triazines; 1,3,5-oxadiazepines; and thiazolopyrimidines derived from visnaginone and khellinone as anti-inflammatory and analgesic agents. Molecules, 25.","DOI":"10.3390\/molecules25010220"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/jhet.4527","article-title":"Ultrasound assisted synthesis of 5\u20137 membered heterocyclic rings in organic molecules","volume":"59","author":"Shabir","year":"2022","journal-title":"J. Heterocycl. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pivarcsik, T., T\u00f3th, G., Szemer\u00e9di, N., Bogdanov, A., Spengler, G., Kljun, J., Kladnik, J., Turel, I., and Enyedy, \u00c9.A. (2021). Comparison of solution chemical properties and biological activity of ruthenium complexes of selected \u03b2-diketone, 8-hydroxyquinoline and pyrithione ligands. Pharmaceuticals, 14.","DOI":"10.3390\/ph14060518"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1080\/00397911.2021.1941114","article-title":"Dicarbonyl compounds in O-heterocycle synthesis","volume":"51","author":"Kaur","year":"2021","journal-title":"Synth. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/1570179418666211011141428","article-title":"Recent Progress in the Synthesis of Heterocycles based on 1,3-diketones","volume":"19","author":"Talbi","year":"2022","journal-title":"Curr. Org. Synth."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S2453","DOI":"10.1016\/j.arabjc.2013.09.009","article-title":"Studies on condensation of 1,3-dicarbonyls with malononitrile: Synthesis of 2-pyridinones","volume":"10","author":"Seifi","year":"2017","journal-title":"Arab. J. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"de Gonzalo, G., and Alc\u00e1ntara, A.R. (2021). Recent Developments in the Synthesis of \u03b2-Diketones. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101043"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"692168","DOI":"10.3389\/fchem.2021.692168","article-title":"Catalytic dyad residues His41 and Cys145 impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease","volume":"9","author":"Ferreira","year":"2021","journal-title":"Front. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Khalifa, I., Zhu, W., Mohammed, H.H.H., Dutta, K., and Li, C. (2020). Tannins inhibit SARS-CoV-2 through binding with cat-alytic dyad residues of 3CLpro: An in silico approach with 19 structural different hydrolysable tannins. J. Food Bio-Chem., 44.","DOI":"10.1111\/jfbc.13432"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10900-020-00863-3","article-title":"Epidemic Trend of COVID-19 transmission in India during lockdown-1 phase","volume":"45","author":"Mahajan","year":"2020","journal-title":"J. Community Health"},{"key":"ref_22","first-page":"219","article-title":"CNS implications of COVID-19: A comprehensive review","volume":"32","author":"Nagu","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.22159\/ijap.2020v12i5.38439","article-title":"COVID-19: Epidemiology, patho-genicity and global updates","volume":"12","author":"Singh","year":"2020","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/2211738508666201016151850","article-title":"Antiviral Essential oils incorporated in nanocarriers: Strategy for prevention from COVID-19 and future infectious pandemics","volume":"8","author":"Kaur","year":"2020","journal-title":"Pharm. Nanotechnol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"198146","DOI":"10.1016\/j.virusres.2020.198146","article-title":"Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19","volume":"289","author":"Choudhary","year":"2020","journal-title":"Virus Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/acsmedchemlett.8b00583","article-title":"Scaffold morphing approach to expand the toolbox of broad-spectrum antivirals blocking dengue\/Zika replication","volume":"10","author":"Vincetti","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2174\/1573409915666190704093400","article-title":"MolOpt: A web server for drug design using bioisosteric transformation","volume":"16","author":"Shan","year":"2020","journal-title":"Curr. Comput. Aided-Drug Des."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2042098612469335","article-title":"The ABCD of clinical pharmacokinetics","volume":"4","author":"Doogue","year":"2013","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fphar.2019.00434","article-title":"In silico ADME and toxicity prediction of ceftazidime and its impurities","volume":"10","author":"Han","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1016\/j.bmc.2017.09.012","article-title":"Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer\u2019s disease: Design, synthesis and biological evaluations","volume":"25","author":"Singh","year":"2017","journal-title":"Bioorganic Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (Aricept\u00ae): Implications for the design of new anti-Alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch. Pharmacal Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s42535-020-00162-1","article-title":"Molecular docking analysis of selected phytochemicals against SARS-CoV-2 M pro receptor","volume":"33","author":"Garg","year":"2020","journal-title":"Vegetos"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: A case study of CDOCKER\u2014A CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J. Comput. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Shafiq, M., Sherwani, Z.A., Mushtaq, M., Nur-E-Alam, M., Ahmad, A., and Ul-Haq, Z. (2024). A deep learning-based theoretical protocol to identify potentially isoform-selective PI3K\u03b1 inhibitors. Mol. Divers., 1\u201318.","DOI":"10.1007\/s11030-023-10799-0"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1080\/07391102.2019.1650830","article-title":"Development of a theoretical model for the inhibition of nsP3 of Chikungunya virus using pyranooxazoles","volume":"38","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bowers, K.J., Chow, E., Xu, H., Dror, R.O., Eastwood, M.P., Gregersen, B.A., Klepeis, J.L., Kolossvary, I., Moraes, M.A., and Sac-erdoti, F.D. (2006, January 11). Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, New York, NY, USA.","DOI":"10.1145\/1188455.1188544"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"114131","DOI":"10.1016\/j.comptc.2023.114131","article-title":"Molecular dynamics simulation of the inhibition mechanism of factor XIa by Milvexian-like macrocyclic inhibitors","volume":"1225","author":"Li","year":"2023","journal-title":"Comput. Theor. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kumar, V., Parate, S., Zeb, A., Singh, P., Lee, G., Jung, T.S., Lee, K.W., and Ha, M.W. (2022). 3D-QSAR-based pharmacophore modeling, virtual screening, and molecular dynamics simulations for the identification of spleen tyrosine kinase inhibitors. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.909111"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s44321-023-00014-w","article-title":"Methotrimeprazine is a neuroprotective antiviral in JEV infection via adaptive ER stress and autophagy","volume":"16","author":"Prajapat","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.csbj.2021.04.014","article-title":"Identifi-cation of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity","volume":"19","author":"Kumar","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/6\/1406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:17:25Z","timestamp":1760105845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/6\/1406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["molecules29061406"],"URL":"https:\/\/doi.org\/10.3390\/molecules29061406","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]}}}